These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2932655)

  • 1. Lipid storage myopathy in Kearns-Sayre syndrome.
    Niebrój-Dobosz I; Ryniewicz B; Fidziańska A; Badurska B
    Neurology; 1985 Nov; 35(11):1582-6. PubMed ID: 2932655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-lipid-glycogen myopathy, hyperlactacidemia, and carnitine deficiency.
    Di Donato S; Cornelio F; Balestrini MR; Bertagnolio B; Peluchetti D
    Neurology; 1978 Nov; 28(11):1110-6. PubMed ID: 568729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate.
    Allen RJ; DiMauro S; Coulter DL; Papadimitriou A; Rothenberg SP
    Ann Neurol; 1983 Jun; 13(6):679-82. PubMed ID: 6881930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kearns-Sayre syndrome: mitochondrial encephalomyopathy caused by deficiency of the respiratory chain].
    Desnuelle C; Pellissier JF; Serratrice G; Pouget J; Turnbull DM
    Rev Neurol (Paris); 1989; 145(12):842-50. PubMed ID: 2559448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial encephalomyopathies.
    Scarlato G; Moggio M; Bet L; Gallanti A; Bresolin N
    Acta Neurol (Napoli); 1989 Oct; 11(5):322-9. PubMed ID: 2603778
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mitochondrial myopathy and abnormal mitochondrial DNA].
    Takeshita K
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):834-8. PubMed ID: 3152098
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunocytological and histochemical correlation in Kearns-Sayre syndrome with mtDNA deletion and partial cytochrome c oxidase deficiency in skeletal muscle.
    Romero NB; Lestienne P; Marsac C; Paturneau-Jouas M; Nelson I; François D; Eymard B; Fardeau M
    J Neurol Sci; 1989 Nov; 93(2-3):297-309. PubMed ID: 2556504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disorders of folate metabolism in the Kearns-Sayre syndrome].
    Macron JM; Mizon JP; Rosa A
    Rev Neurol (Paris); 1983; 139(11):673-7. PubMed ID: 6677979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of lipid storage myopathy with carnitine deficiency. Biochemical and electromyographic correlations.
    Scarlato G; Albizzati MG; Bassi S; Cerri C; Frattola L
    Eur Neurol; 1977; 16(1-6):222-9. PubMed ID: 615713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome.
    Goto Y; Itami N; Kajii N; Tochimaru H; Endo M; Horai S
    J Pediatr; 1990 Jun; 116(6):904-10. PubMed ID: 2161456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant Kearns-Sayre syndrome.
    Leveille AS; Newell FW
    Ophthalmology; 1980 Feb; 87(2):99-108. PubMed ID: 7383548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome.
    Shanske S; Moraes CT; Lombes A; Miranda AF; Bonilla E; Lewis P; Whelan MA; Ellsworth CA; DiMauro S
    Neurology; 1990 Jan; 40(1):24-8. PubMed ID: 2296377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [31P-NMR spectroscopy of mitochondrial myopathies: the relation between abnormal energy metabolism and muscle biopsy findings].
    Kawai M; Itoh M; Okazawa H; Kamakura K
    Rinsho Shinkeigaku; 1989 Feb; 29(2):167-71. PubMed ID: 2546706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disorders of folate metabolism in the Kearns-Sayre syndrome].
    Laplane D; Hasboun D
    Rev Otoneuroophtalmol; 1984; 56(2):199-202. PubMed ID: 6474025
    [No Abstract]   [Full Text] [Related]  

  • 15. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34-1987. A 30-year-old woman with an ocular motility disturbance, myopathy, and hypocalcemia.
    N Engl J Med; 1987 Aug; 317(8):493-501. PubMed ID: 3614294
    [No Abstract]   [Full Text] [Related]  

  • 16. Kearns-Sayre syndrome: biochemical studies of mitochondrial metabolism.
    Martens ME; Peterson PL; Lee CP; Nigro MA; Hart Z; Glasberg M; Hatfield JS; Chang CH
    Ann Neurol; 1988 Nov; 24(5):630-7. PubMed ID: 2849368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes.
    Zupanc ML; Moraes CT; Shanske S; Langman CB; Ciafaloni E; DiMauro S
    Ann Neurol; 1991 Jun; 29(6):680-3. PubMed ID: 1892371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate metabolism disorder in Kearns-Sayre syndrome.
    Dougados M; Zittoun J; Laplane D; Castaigne P
    Ann Neurol; 1983 Jun; 13(6):687. PubMed ID: 6881934
    [No Abstract]   [Full Text] [Related]  

  • 19. High CSF lactate and pyruvate content in Kearns-Sayre syndrome.
    Kuriyama M; Suehara M; Marume N; Osame M; Igata A
    Neurology; 1984 Feb; 34(2):253-5. PubMed ID: 6538023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus.
    Zierz S; Jahns G; Jerusalem F
    J Neurol; 1989 Feb; 236(2):97-101. PubMed ID: 2709060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.